Camp RL - Search Results

1

Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.

Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL, Rimm DL. Kielhorn E, et al. Among authors: camp rl. Int J Cancer. 2003 Feb 20;103(5):652-6. doi: 10.1002/ijc.10893. Int J Cancer. 2003. PMID: 12494474

2

Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.

Chung GG, Yoon HH, Zerkowski MP, Ghosh S, Thomas L, Harigopal M, Charette LA, Salem RR, Camp RL, Rimm DL, Burtness BA. Chung GG, et al. Among authors: camp rl. Cancer. 2006 Apr 15;106(8):1677-84. doi: 10.1002/cncr.21783. Cancer. 2006. PMID: 16532435 Free article.

3

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Among authors: camp rl. Cancer Res. 2006 May 15;66(10):5487-94. doi: 10.1158/0008-5472.CAN-06-0100. Cancer Res. 2006. PMID: 16707478

4

Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.

Zerkowski MP, Camp RL, Burtness BA, Rimm DL, Chung GG. Zerkowski MP, et al. Among authors: camp rl. Cancer Invest. 2007 Feb;25(1):19-26. doi: 10.1080/07357900601128825. Cancer Invest. 2007. PMID: 17364553

5

High HSP90 expression is associated with decreased survival in breast cancer.

Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. Pick E, et al. Among authors: camp rl. Cancer Res. 2007 Apr 1;67(7):2932-7. doi: 10.1158/0008-5472.CAN-06-4511. Cancer Res. 2007. PMID: 17409397

6

Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.

Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL. Harigopal M, et al. Among authors: camp rl. Breast Cancer Res Treat. 2009 May;115(1):77-85. doi: 10.1007/s10549-008-0063-9. Epub 2008 Jun 3. Breast Cancer Res Treat. 2009. PMID: 18521745

7

Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.

Giltnane JM, Moeder CB, Camp RL, Rimm DL. Giltnane JM, et al. Among authors: camp rl. Cancer. 2009 Jun 1;115(11):2400-9. doi: 10.1002/cncr.24277. Cancer. 2009. PMID: 19330842 Free PMC article.

8

Automated subcellular localization and quantification of protein expression in tissue microarrays.

Camp RL, Chung GG, Rimm DL. Camp RL, et al. Nat Med. 2002 Nov;8(11):1323-7. doi: 10.1038/nm791. Epub 2002 Oct 21. Nat Med. 2002. PMID: 12389040

9

Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.

Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Dolled-Filhart M, et al. Among authors: camp rl. Clin Cancer Res. 2003 Feb;9(2):594-600. Clin Cancer Res. 2003. PMID: 12576423

10

Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL. Kang JY, et al. Among authors: camp rl. Cancer Res. 2003 Mar 1;63(5):1101-5. Cancer Res. 2003. PMID: 12615728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters